{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:52:13Z","timestamp":1778158333726,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.clon.2014.10.002","type":"journal-article","created":{"date-parts":[[2014,10,29]],"date-time":"2014-10-29T22:52:48Z","timestamp":1414623168000},"page":"153-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Outcomes of Primary Lymphoma of the Ocular Adnexa (Orbital Lymphoma) Treated with Radiotherapy"],"prefix":"10.1016","volume":"27","author":[{"given":"D.K.","family":"Woolf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kuhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Shoffren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.M.","family":"Akinnawo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Sivagurunathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Boyce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.N.","family":"Plowman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2014.10.002_bib1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/1097-0142(197201)29:1<252::AID-CNCR2820290138>3.0.CO;2-#","article-title":"Occurrence and prognosis of extranodal lymphomas","volume":"29","author":"Freeman","year":"1972","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2014.10.002_bib2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0360-3016(84)90051-8","article-title":"Lymphoreticular tumors of the orbit","volume":"10","author":"Fitzpatrick","year":"1984","journal-title":"Radiat Oncol Biol"},{"key":"10.1016\/j.clon.2014.10.002_bib3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.clon.2012.03.001","article-title":"Primary lymphoma of the ocular adnexa (orbital lymphoma) and primary intraocular lymphoma","volume":"24","author":"Woolf","year":"2012","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2014.10.002_bib4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0167-8140(88)90218-6","article-title":"Orbital and conjunctival lymphoma treatment and prognosis","volume":"13","author":"Bessell","year":"1988","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2014.10.002_bib5","first-page":"1860","article-title":"Report of the committee on Hodgkin's disease staging classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"key":"10.1016\/j.clon.2014.10.002_bib6","doi-asserted-by":"crossref","first-page":"e659","DOI":"10.1016\/j.ijrobp.2011.03.050","article-title":"Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: efficacy and toxicity","volume":"81","author":"Goda","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2014.10.002_bib7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijrobp.2005.11.035","article-title":"Orbital marginal zone B-cell lymphoma of MALT: radiotherapy results and clinical behavior","volume":"65","author":"Suh","year":"2006","journal-title":"Radiat Oncol Biol"},{"key":"10.1016\/j.clon.2014.10.002_bib8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijrobp.2009.04.018","article-title":"Primary radiation therapy in patients with localized orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma)","volume":"77","author":"Son","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2014.10.002_bib9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.radonc.2008.09.011","article-title":"Radiotherapy and oncology","volume":"90","author":"Nam","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2014.10.002_bib10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3109\/10428194.2012.717279","article-title":"Efficacy of low dose radiotherapy for primary orbital marginal zone lymphoma","volume":"54","author":"Tran","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clon.2014.10.002_bib11","first-page":"5575","article-title":"Radiotherapy for early-stage primary ocular adnexal mucosa-associated lymphoid tissue lymphoma","volume":"33","author":"Ohga","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clon.2014.10.002_bib12","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.ijrobp.2011.04.052","article-title":"Long-term outcome and patterns of failure in primary ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy","volume":"82","author":"Hashimoto","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2014.10.002_bib13","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.ijrobp.2010.07.1992","article-title":"Treatment effects and sequelae of radiation therapy for orbital mucosa-associated lymphoid tissue lymphoma","volume":"81","author":"Hata","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2014.10.002_bib14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.clml.2013.10.011","article-title":"Clinical characteristics of 95 patients with ocular adnexal and uveal lymphoma: treatment outcomes in extranodal marginal zone subtype","volume":"14","author":"Portell","year":"2014","journal-title":"Clin Lymphoma Myeloma Leukemia"},{"key":"10.1016\/j.clon.2014.10.002_bib15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2141.2010.08429.x","article-title":"Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): single institution experience in a large cohort of patients","volume":"152","author":"Bayraktar","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clon.2014.10.002_bib16","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.ijrobp.2007.04.029","article-title":"A\u00a0multicenter phase II study of local radiation therapy for stage IEA mucosa-associated lymphoid tissue lymphomas: a preliminary report from the Japan Radiation Oncology Group (JAROG)","volume":"69","author":"Isobe","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2014.10.002_bib17","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0360-3016(02)02966-8","article-title":"Curative radiotherapy for primary orbital lymphoma","volume":"54","author":"Bhatia","year":"2002","journal-title":"Radiat Oncol Biol"},{"key":"10.1016\/j.clon.2014.10.002_bib18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0167-8140(00)00328-5","article-title":"Orbital lymphoma: radiotherapy outcome and complications","volume":"59","author":"Stafford","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2014.10.002_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0360-3016(98)00535-5","article-title":"Radiotherapy in the management of orbital lymphoma","volume":"44","author":"Bolek","year":"1999","journal-title":"Radiat Oncol Biol"},{"key":"10.1016\/j.clon.2014.10.002_bib20","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0360-3016(02)04159-7","article-title":"Outcome and prognostic factors in orbital lymphoma: a Rare Cancer Network study on 90 consecutive patients treated with radiotherapy","volume":"55","author":"Martinet","year":"2003","journal-title":"Radiat Oncol Biol"},{"key":"10.1016\/j.clon.2014.10.002_bib21","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ijrobp.2005.03.005","article-title":"Radiation therapy for orbital lymphoma","volume":"63","author":"Zhou","year":"2005","journal-title":"Radiat Oncol Biol"},{"key":"10.1016\/j.clon.2014.10.002_bib22","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0360-3016(03)00506-6","article-title":"Treatment results of radiotherapy for malignant lymphoma of the orbit and histopathologic review according to the WHO classification","volume":"57","author":"Hasegawa","year":"2003","journal-title":"Radiat Oncol Biol"},{"key":"10.1016\/j.clon.2014.10.002_bib23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1748-717X-4-60","article-title":"Radiation therapy in primary orbital lymphoma: a single institution retrospective analysis","volume":"4","author":"De Cicco","year":"2009","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.clon.2014.10.002_bib24","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1159\/000104766","article-title":"Indolent stage IE non-Hodgkin's lymphoma of the orbit: results after primary radiotherapy","volume":"221","author":"Bischof","year":"2007","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.clon.2014.10.002_bib25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4103\/0301-4738.81993","article-title":"Extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue type of the ocular adnexa: retrospective single institution review of 95 patients","volume":"59","author":"Lim","year":"2011","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.clon.2014.10.002_bib26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/IOP.0b013e31821cc4bb","article-title":"Primary, unilateral ocular adnexal lymphoma: disease progression and long-term survival","volume":"27","author":"Rootman","year":"2011","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.clon.2014.10.002_bib27","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1470-2045(14)70036-1","article-title":"4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial","volume":"15","author":"Hoskin","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2014.10.002_bib28","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1002\/cncr.25226","article-title":"Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy","volume":"116","author":"Goda","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2014.10.002_bib29","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/cncr.27773","article-title":"Survival of patients with marginal zone lymphoma","volume":"119","author":"Olszewski","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2014.10.002_bib30","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1136\/bmj.316.7145.1643","article-title":"Prevalence of serious eye disease and visual impairment in a north London population: population based, cross sectional study","volume":"316","author":"Reidy","year":"1998","journal-title":"Br Med J"},{"key":"10.1016\/j.clon.2014.10.002_bib31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/08820530500351728","article-title":"Radiotherapy and cataract formation","volume":"21","author":"Ferrufino-Ponce","year":"2006","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.clon.2014.10.002_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1667\/RR1688.1","article-title":"Radiation cataractogenesis: a review of recent studies","volume":"172","author":"Ainsbury","year":"2009","journal-title":"Radiat Res"},{"key":"10.1016\/j.clon.2014.10.002_bib33","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ijrobp.2010.09.056","article-title":"Ocular risks from orbital and periorbital radiation therapy: a critical review","volume":"79","author":"Jeganathan","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2014.10.002_bib34","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3341\/kjo.2013.27.4.243","article-title":"Risk Potentiality of frontline radiotherapy associated cataract in primary ocular adnexal mucosa-associated lymphoid tissue lymphoma","volume":"27","author":"Cho","year":"2013","journal-title":"Korean J Ophthalmol"},{"key":"10.1016\/j.clon.2014.10.002_bib35","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ijrobp.2004.03.039","article-title":"Orbital lymphoma: is it necessary to treat the entire orbit?","volume":"60","author":"Pfeffer","year":"2004","journal-title":"Radiat Oncol Biol"},{"key":"10.1016\/j.clon.2014.10.002_bib36","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/sj.eye.6700379","article-title":"Clinical features associated with survival of patients with lymphoma of the ocular adnexa","volume":"17","author":"Jenkins","year":"2003","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.clon.2014.10.002_bib37","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3928\/15428877-20070701-08","article-title":"Value of positron emission tomography in staging ocular adnexal lymphomas and evaluating their response to therapy","volume":"38","author":"Gayed","year":"2007","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"10.1016\/j.clon.2014.10.002_bib38","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1182\/blood-2008-12-195453","article-title":"Extranodal marginal zone lymphoma of the ocular adnexa","volume":"114","author":"Stefanovic","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clon.2014.10.002_bib39","doi-asserted-by":"crossref","first-page":"e104004","DOI":"10.1371\/journal.pone.0104004","article-title":"Clinical features, treatment and outcome of mucosa-associated lymphoid tissue (MALT) lymphoma of the ocular adnexa: single center experience of 60 patients","volume":"9","author":"Kiesewetter","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.clon.2014.10.002_bib40","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1182\/blood-2005-06-2332","article-title":"Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci","volume":"107","author":"Rosado","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.clon.2014.10.002_bib41","series-title":"AJCC cancer staging handbook","author":"Edge","year":"2009"},{"key":"10.1016\/j.clon.2014.10.002_bib42","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/01676830.2013.842257","article-title":"Comparison of American Joint Committee on Cancer TNM-based staging system (7th edition) and Ann Arbor classification for predicting outcome in ocular adnexal lymphoma","volume":"33","author":"Rath","year":"2014","journal-title":"Orbit"},{"key":"10.1016\/j.clon.2014.10.002_bib43","doi-asserted-by":"crossref","first-page":"344","DOI":"10.5301\/ejo.5000224","article-title":"Ocular adnexal lymphoma staging and treatment: American Joint Committee on Cancer versus Ann Arbor","volume":"23","author":"Graue","year":"2013","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.clon.2014.10.002_bib44","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0360-3016(03)00767-3","article-title":"Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes","volume":"57","author":"Fung","year":"2003","journal-title":"Radiat Oncol Biol"},{"key":"10.1016\/j.clon.2014.10.002_bib45","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/jnci\/djh102","article-title":"Evidence for an association between chlamydia psittaci and ocular adnexal lymphomas","volume":"96","author":"Ferreri","year":"2004","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clon.2014.10.002_bib46","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1200\/JCO.2011.41.4466","article-title":"Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial","volume":"30","author":"Ferreri","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2014.10.002_bib47","article-title":"Rituximab alone in the management of primary orbital lymphoma of the conjunctiva","author":"Woolf","year":"2012","journal-title":"NCRI Conference"},{"key":"10.1016\/j.clon.2014.10.002_bib48","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/annonc\/mdn692","article-title":"Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma","volume":"20","author":"Esmaeli","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2014.10.002_bib49","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/sim.4780040202","article-title":"The 2 \u00d7 2 factorial design: its application to a randomized trial of aspirin and carotene in U.S. physicians","volume":"4","author":"Stampfer","year":"1985","journal-title":"Stat Med"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655514003768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655514003768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:40:42Z","timestamp":1760542842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655514003768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0936655514003768"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2014.10.002","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of Primary Lymphoma of the Ocular Adnexa (Orbital Lymphoma) Treated with Radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2014.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}